| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 口服制剂(元) | 134,063,360.61 | 62,497,359.64 | 110,594,289.17 | 54,131,147.55 |
| 外用制剂(元) | 53,031,258.45 | 60,574,469.04 | 46,502,358.16 | 26,440,374.25 |
| 其他主营业务(元) | - | - | - | 219,832.03 |
| 营业成本(元) | ||||
| 口服制剂(元) | 36,219,097.93 | 18,757,151.09 | 28,683,493.63 | 11,920,892.28 |
| 外用制剂(元) | 17,534,824.29 | 17,311,074.65 | 14,585,315.14 | 5,858,946.22 |
| 其他主营业务(元) | - | - | - | 66,055.69 |
| 毛利(元) | ||||
| 口服制剂(元) | 97,844,262.68 | 43,740,208.55 | 81,910,795.54 | 42,210,255.27 |
| 外用制剂(元) | 35,496,434.16 | 43,263,394.39 | 31,917,043.02 | 20,581,428.03 |
| 其他主营业务(元) | - | - | - | 153,776.34 |
| 毛利率(%) | ||||
| 口服制剂(%) | 72.98 | 69.99 | 74.06 | 77.98 |
| 外用制剂(%) | 66.93 | 71.42 | 68.64 | 77.84 |
| 其他主营业务(%) | - | - | - | 69.95 |
| 收入构成(%) | ||||
| 口服制剂(%) | 71.66 | 50.78 | 70.40 | 67.00 |
| 外用制剂(%) | 28.34 | 49.22 | 29.60 | 32.73 |
| 其他主营业务(%) | - | - | - | 0.27 |
| 毛利构成(%) | ||||
| 口服制剂(%) | 73.38 | 50.27 | 71.96 | 67.06 |
| 外用制剂(%) | 26.62 | 49.73 | 28.04 | 32.70 |
| 其他主营业务(%) | - | - | - | 0.24 |